By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Dynavax Technologies Corporation

Dynavax Technologies Corporation (0IDA.L)

LSE Currency in USD
$10.50
-$0.14
-1.30%
Last Update: 17 Jul 2025, 06:18
$1.26B
Market Cap
-19.74
P/E Ratio (TTM)
Forward Dividend Yield
$9.50 - $15.15
52 Week Range

0IDA.L Stock Price Chart

Explore Dynavax Technologies Corporation interactive price chart. Choose custom timeframes to analyze 0IDA.L price movements and trends.

There is nothing to show.

0IDA.L Company Profile

Discover essential business fundamentals and corporate details for Dynavax Technologies Corporation (0IDA.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

29 Jan 2018

Employees

405.00

CEO

Ryan Spencer

Description

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

0IDA.L Financial Timeline

Browse a chronological timeline of Dynavax Technologies Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 4 May 2026

Upcoming earnings on 18 Feb 2026

Upcoming earnings on 5 Nov 2025

Upcoming earnings on 4 Aug 2025

Revenue estimate is $87.55M.

Earnings released on 6 May 2025

EPS came in at -$0.77 falling short of the estimated $0.03 by -2.78K%, while revenue for the quarter reached $68.16M, missing expectations by -19.00%.

Earnings released on 20 Feb 2025

EPS came in at $0.05 surpassing the estimated $0.04 by +10.11%, while revenue for the quarter reached $72.03M, missing expectations by -0.92%.

Earnings released on 8 Nov 2024

EPS came in at $0.12 surpassing the estimated $0.11 by +5.91%, while revenue for the quarter reached $80.63M, beating expectations by +12.43%.

Earnings released on 7 Aug 2024

EPS came in at $0.07 surpassing the estimated $0.06 by +14.21%, while revenue for the quarter reached $73.80M, missing expectations by -2.96%.

Earnings released on 9 May 2024

EPS came in at -$0.07 falling short of the estimated -$0.02 by -184.17%, while revenue for the quarter reached $50.79M, missing expectations by -7.61%.

Earnings released on 4 Mar 2024

EPS came in at $0.00 surpassing the estimated -$0.01 by +115.53%, while revenue for the quarter reached $55.60M, beating expectations by +5.44%.

Earnings released on 3 Nov 2023

EPS came in at $0.09 surpassing the estimated -$0.04 by +345.47%, while revenue for the quarter reached $69.51M, beating expectations by +15.28%.

Earnings released on 4 Aug 2023

EPS came in at $0.03 surpassing the estimated -$0.09 by +128.72%, while revenue for the quarter reached $60.25M, beating expectations by +24.50%.

Earnings released on 3 May 2023

EPS came in at -$0.19 falling short of the estimated -$0.13 by -43.55%, while revenue for the quarter reached $46.93M, beating expectations by +21.62%.

Earnings released on 24 Feb 2023

EPS came in at $0.45 surpassing the estimated $0.41 by +8.43%, while revenue for the quarter reached $184.49M, beating expectations by +2.72%.

Earnings released on 30 Sept 2022

EPS came in at $0.42 surpassing the estimated $0.30 by +41.93%, while revenue for the quarter reached $167.74M, beating expectations by +5.22%.

Earnings released on 30 Jun 2022

EPS came in at $0.86 surpassing the estimated $0.23 by +277.58%, while revenue for the quarter reached $256.46M, beating expectations by +69.85%.

Earnings released on 31 Mar 2022

EPS came in at $0.22 falling short of the estimated $0.28 by -21.79%, while revenue for the quarter reached $113.99M, missing expectations by -26.12%.

Dividend declared on 15 Mar 2022

A dividend of $0.29 per share was announced, adjusted to $0.29.

Earnings released on 23 Feb 2022

EPS came in at $0.77 surpassing the estimated $0.64 by +20.94%, while revenue for the quarter reached $195.07M, missing expectations by -6.61%.

Earnings released on 4 Nov 2021

EPS came in at $0.03, while revenue for the quarter reached $52.77M.

Earnings released on 30 Sept 2021

EPS came in at -$0.24, while revenue for the quarter reached $105.87M.

Earnings released on 31 Mar 2021

EPS came in at $0.01, while revenue for the quarter reached $83.34M.

Earnings released on 31 Dec 2020

EPS came in at -$0.14, while revenue for the quarter reached $13.25M.

Earnings released on 30 Sept 2020

EPS came in at $0.04, while revenue for the quarter reached $13.41M.

0IDA.L Stock Performance

Access detailed 0IDA.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
0IDA.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
0IDA.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More